{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T22:03:45Z","timestamp":1790892225924,"version":"4.1.0"},"reference-count":20,"publisher":"SAGE Publications","license":[{"start":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T00:00:00Z","timestamp":1790726400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T00:00:00Z","timestamp":1790726400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Journal of Aerosol Medicine and Pulmonary Drug Delivery"],"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Efficient aerosol therapy depends on both device performance and inhalation technique. Breath-triggered vibrating mesh nebulizers reduce drug loss by generating aerosol only during inspiration but may prolong treatment. Guiding patients toward slow, deep breathing could improve lung deposition and shorten nebulization time, yet quantitative evidence, particularly across disease groups, remains limited.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective:<\/jats:title>\n                    <jats:p>To assess how integrated breath-guiding features influence breathing behavior, lung deposition, and user perception in healthy adults and in patients with obstructive or restrictive lung disease.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>\n                      Sixty-four participants inhaled through three nebulizer configurations: a low-resistance reference (eFlow OS) and two versions of the eFlow Integrated featuring direction-dependent resistance and multimodal feedback, tested with or without a breath-guiding app. Flow signals from multiple breaths were analyzed to determine phase-averaged breathing parameters. Device effects were evaluated by ANOVA. Representative breathing patterns and unsteady aerosol characteristics were input to a validated whole-lung\n                      <jats:italic toggle=\"yes\">in silico<\/jats:italic>\n                      model to estimate deposition. User experience was assessed by questionnaire.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      Breath-guiding consistently altered inhalation behavior. Peak inspiratory flow decreased by \u223c20%, the I\/E ratio increased by &gt;15%, and with the breath guide app, tidal volume (+40%) and breath duration (+47%) increased. These effects were similar across disease groups.\n                      <jats:italic toggle=\"yes\">In silico<\/jats:italic>\n                      simulations showed improved delivery with guided inhalation: lung drug deposition rate increased by 3.7% and 15.5%, and alveolar deposited mass fraction rose by 66% and 76% versus the reference. The breath guide app further shifted deposition from extrathoracic to thoracic and alveolar regions and reduced exhalation losses (\u201314%). Most participants (88%) were satisfied or very satisfied, citing pleasant resistance and helpful app guidance.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Breath-guiding features and digital coaching reliably promote slower, deeper breathing, leading to greater lung and alveolar deposition and shorter expected nebulization times. High user acceptance underscores the clinical potential of patient-centric, guided inhalation in optimizing aerosol therapy.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/19412711261488960","type":"journal-article","created":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T09:57:46Z","timestamp":1790762266000},"update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":0,"title":["Effect of Nebulizer Breath-Guiding on Breathing Patterns and Lung Deposition"],"prefix":"10.1177","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-2683-7629","authenticated-orcid":false,"given":"Benjamin","family":"Heine","sequence":"first","affiliation":[{"name":"PARI Pharma GmbH, Starnberg, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uwe","family":"Schuschnig","sequence":"additional","affiliation":[{"name":"PARI Pharma GmbH, Starnberg, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-4959-6409","authenticated-orcid":false,"given":"Jakob","family":"Richter","sequence":"additional","affiliation":[{"name":"Ebenbuild GmbH, Munich, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Liebl","sequence":"additional","affiliation":[{"name":"PARI Pharma GmbH, Starnberg, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lea","family":"Botermann","sequence":"additional","affiliation":[{"name":"PARI GmbH, Starnberg, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gesa","family":"Br\u00e4unlich","sequence":"additional","affiliation":[{"name":"PARI Pharma GmbH, Starnberg, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1716-1460","authenticated-orcid":false,"given":"Nicolas","family":"Schwenck","sequence":"additional","affiliation":[{"name":"Ebenbuild GmbH, Munich, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1680-0259","authenticated-orcid":false,"given":"Maximilian J.","family":"Grill","sequence":"additional","affiliation":[{"name":"Ebenbuild GmbH, Munich, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Hahn","sequence":"additional","affiliation":[{"name":"PARI Pharma GmbH, Starnberg, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2026,9,30]]},"reference":[{"key":"e_1_3_2_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcf.2011.04.006"},{"key":"e_1_3_2_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcf.2008.09.007"},{"key":"e_1_3_2_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2006.07.009"},{"key":"e_1_3_2_5_1","doi-asserted-by":"publisher","DOI":"10.1089\/jamp.2009.0786"},{"key":"e_1_3_2_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2011.01.005"},{"key":"e_1_3_2_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaerosci.2025.106620"},{"key":"e_1_3_2_8_1","volume-title":"Drug delivery to the lung","author":"Cuevas Brun E","year":"2024","unstructured":"7.Cuevas Brun E, , Richter J, , Grill M, et al. Adaptive breath-actuated mesh nebulisers: Using in silico evidence to demonstrate optimisation of lung deposition. In: Drug delivery to the lung. DDL: Edinburgh; 2024."},{"key":"e_1_3_2_9_1","volume-title":"Drug Delivery to the Lungs","author":"Carolina Dantas KU","year":"2024","unstructured":"8.Carolina Dantas KU, , Ganley W, , Bootle R, et al. Assessing the impact of realistic breathing profiles in aerosol deposition using in-silico methods. In: Drug Delivery to the Lungs. DDL: Edinburgh, 2024."},{"issue":"1","key":"e_1_3_2_10_1","article-title":"In silico high-resolution whole lung model to predict the locally delivered dose of inhaled drugs","volume":"6","author":"Grill M","year":"2026","unstructured":"9.Grill M, , Biehler J, , Wichmann K-R, et al. In silico high-resolution whole lung model to predict the locally delivered dose of inhaled drugs. Commun Med (Lond) 2026;6(1):188\u2013112.","journal-title":"Commun Med (Lond)"},{"issue":"61","key":"e_1_3_2_11_1","first-page":"71","article-title":"Impact of normal, obstructive, and restrictive breathing patterns on aerosol drug delivery with jet and mesh nebulizers in simulated spontaneously breathing adults","volume":"15","author":"Ari A","year":"2025","unstructured":"10.Ari A, , Hoops J, , Williams Z, et al. Impact of normal, obstructive, and restrictive breathing patterns on aerosol drug delivery with jet and mesh nebulizers in simulated spontaneously breathing adults. Can J Respir Ther 2025;15(61):71\u201376.","journal-title":"Can J Respir Ther"},{"key":"e_1_3_2_12_1","first-page":"16","article-title":"Deep Breaths, Deep Dives: The New eFlow Integrated Nebulizer","volume":"158","author":"Braeunlich G","year":"2024","unstructured":"11.Braeunlich G, , Hahn M. Deep Breaths, Deep Dives: The New eFlow Integrated Nebulizer. OnDrugDelivery 2024;158:16\u201319.","journal-title":"OnDrugDelivery"},{"key":"e_1_3_2_13_1","first-page":"305","article-title":"Unsteady aerosol output rate measurements: Assessing the eFlow nebulizer aerosol bolus","author":"Heine B","year":"2022","unstructured":"12.Heine B, , Keller J, , Dietsche J, et al. Unsteady aerosol output rate measurements: Assessing the eFlow nebulizer aerosol bolus. Respiratory Drug Delivery 2022:305\u2013308.","journal-title":"Respiratory Drug Delivery"},{"key":"e_1_3_2_14_1","article-title":"Steady or not? Using realistic, transient aerosol parameters to predict lung deposition","volume":"34","author":"Grill M","year":"2023","unstructured":"13.Grill M, , Heine B, , Richter J, et al. Steady or not? Using realistic, transient aerosol parameters to predict lung deposition. Drug Delivery to the Lungs 2023;34","journal-title":"Drug Delivery to the Lungs"},{"key":"e_1_3_2_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaerosci.2012.04.006"},{"key":"e_1_3_2_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcf.2015.01.002"},{"key":"e_1_3_2_17_1","doi-asserted-by":"publisher","DOI":"10.1177\/19412711251370277"},{"key":"e_1_3_2_18_1","doi-asserted-by":"publisher","DOI":"10.1089\/jamp.2014.1173"},{"key":"e_1_3_2_19_1","first-page":"2","article-title":"Determining a meaningful r-squared value in clinical medicine","author":"Gupta A","year":"2024","unstructured":"18.Gupta A, , Stead T, , Ganti L. Determining a meaningful r-squared value in clinical medicine. Academic Medicine & Surgery 2024:2\u20136.","journal-title":"Academic Medicine & Surgery"},{"key":"e_1_3_2_20_1","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01499-2021"},{"key":"e_1_3_2_21_1","volume-title":"Restrictive Lung Disease","author":"Tyagi R","year":"2026","unstructured":"20.Tyagi R, , Sankari A. Restrictive Lung Disease. StatPearls Publishing: Treasure Island, FL; 2026."}],"container-title":["Journal of Aerosol Medicine and Pulmonary Drug Delivery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/19412711261488960","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/19412711261488960","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/19412711261488960","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T21:46:47Z","timestamp":1790891207000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/19412711261488960"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,30]]},"references-count":20,"alternative-id":["10.1177\/19412711261488960"],"URL":"https:\/\/doi.org\/10.1177\/19412711261488960","relation":{},"ISSN":["1941-2711","1941-2703"],"issn-type":[{"value":"1941-2711","type":"print"},{"value":"1941-2703","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,30]]},"article-number":"19412711261488960"}}